AdaptHealth Corp.

NASDAQ:AHCO

Medical - Devices

Healthcare
$7.37 +0.10%

+$0.01 today

Market cap
$1.01B
Beta
1.46
P/E (TTM)
-16.3
EPS (TTM)
-$0.59
52W Low $8.06High $13.43

Volume 1.54M

Average 1.38M

AHCO Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

AdaptHealth Corp.NASDAQ: AHCO

Stock-Based Compensation · Q1 FY2026 · quarter ended Apr 2026

Stock-based compensation outflow shrinks to $0

Q1 FY2026 stock-based compensation was $0, compared with $5.3M a year earlier. Trailing-twelve-month stock-based compensation was $11.27M. Over 3 fiscal years it compounded at -0.8% a year.

Context

  • Stock-based compensation amounted to 0.7% of revenue in FY2025, up 0.2 pp from a year earlier.
  • Stock-based compensation increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly stock-based compensation holds near $0 or moves back toward the trailing-twelve-month quarterly average of $2.82M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterApr 2026
$0-100.0% QoQ
Last fiscal yearDec 2025
$21.88M+47.0% YoY
LTMApr 2026
$11.27M-28.3% YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-100.0%——
1 year+47.0%——
3-year CAGR-0.8%——
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

USD · from the cash flow

Latest · FY2025
21.88M USD
Year-over-year change
+47.0%
4-year CAGR
-3.6%

Stock-Based Compensation vs competitors

How AHCO compares with its peers on the latest reported figures

  • AHCO's LTM Apr 2026 stock-based compensation of $11.27M is the 5th largest of the 9 companies compared; the peer median is $14.13M.
  • Its year-over-year change of -28.3% is the lowest of 9, against a peer median of +4.6%.
  • Stock-based compensation amounts to 0.4% of revenue for AHCO, versus a peer median of 3.4%.
AHCO Competitors Peer median
Stock-Based Compensation for AHCO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
RMDResMed Inc.LTM Jun 2026$181.24M +97.7%+13.6%3.2%
INSPInspire Medical Systems, Inc.LTM Jun 2026$119.43M -8.2%+35.8%13.3%
TNDMTandem Diabetes Care, Inc.LTM Mar 2026$82.55M -21.3%+2.8%8.0%
BBNXBeta Bionics, Inc.LTM Mar 2026$18.99M +142.5%+39.0%17.2%
AHCOAdaptHealth Corp.LTM Apr 2026$11.27M -28.3%-0.8%0.4%
VMDViemed Healthcare, Inc.LTM Mar 2026$9.27M +29.4%+20.6%3.2%
INGNInogen, Inc.LTM Mar 2026$7.82M +9.7%-13.3%2.2%
INFUInfuSystem Holdings, Inc.LTM Mar 2026$4.49M -0.5%+4.5%3.2%
ELMDElectromed, Inc.LTM Mar 2026$2.61M -8.5%+46.3%3.6%
Peer median (excluding AHCO) $14.13M+4.6%+17.1%3.4%

Competitors are the stored peer set for AHCO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income158.15M73.13M(678.9M)94.78M(66.04M)
Depreciation & Amortization258.05M351.18M420.59M365.33M381.93M
Deferred Income Tax22.38M18.04M(62.6M)32.05M47.16M
Stock-Based Compensation25.32M22.4M22.47M14.88M21.88M
Change in Working Capital(153.31M)(108M)(25.11M)(26.06M)66.58M
Accounts Receivables(29.69M)(209K)(28.86M)(26.22M)30.99M
Inventory(14.92M)(6.3M)15.53M(28.07M)(11.49M)
Accounts Payables00000
Other Working Capital(108.7M)(101.49M)(11.78M)28.22M47.08M
Other Non-Cash Items(34.92M)17.12M804.2M60.86M150.26M
Operating Cash Flow275.68M373.87M480.67M541.84M601.77M
Capital Expenditures(203.31M)(391.42M)(337.46M)(306.06M)(382.39M)
Acquisitions (Net)(1.62B)(19.02M)(19.69M)(9.54M)(42.38M)
Purchases of Investments(1.13M)(731K)(128K)00
Sales of Investments00000
Other Investing Activities0005.32M121.58M
Investing Cash Flow(1.82B)(411.17M)(357.28M)(310.28M)(303.19M)
Debt Repayment1.4B(36.18M)(51.77M)(179.87M)(268.48M)
Common Stock Issued278.85M0001.21M
Common Stock Repurchased0(13.99M)(29.28M)00
Dividends Paid00000
Other Financing Activities(75.68M)(15.88M)(11.48M)(19.08M)(34.93M)
Financing Cash Flow1.6B(66.05M)(92.53M)(198.95M)(302.19M)
Effect of Forex Changes00000
Net Change in Cash49.67M(103.36M)30.86M32.62M(3.61M)
Free Cash Flow72.37M(17.56M)143.2M235.78M219.38M

AdaptHealth Corp.

NASDAQ:AHCO

Intrinsic Alpha fair value

Locked

Current Price

$7.37

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.